drugset
drugset / Trial / NCT00629317

Trial of Methyl Aminolevulinate Plus Aktilite in Facial Photodamage

NCT00629317 ↗

Phase 3 Completed 49 enrolled Universidad de Antioquia Galderma R&D · collab
RandomizedSingle-groupTriple-blindTreatment

Summary

The aim of the study is to determine the efficacy of MAL + Aktilite versus placebo + Aktilite in facial photodamage in a randomized double blind trial.

Timeline

Start
2008-02
Primary completion
2009-01
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator methyl aminolevulinate Small molecule — Topical

Indications

skin atrophy